Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Cancer Med. 2023 May;12(9):10449-10461. doi: 10.1002/cam4.5780. Epub 2023 Mar 14.
Atypical teratoid rhabdoid tumor (AT/RT) occurs at a younger age and is associated with a worse prognosis than medulloblastoma; however, these two tumor entities are mostly indistinguishable on neuroimaging. The aim of our study was to differentiate AT/RT and medulloblastoma based on their clinical and MRI features to enhance treatment planning and outcome prediction.
From 2005-2021, we retrospectively enrolled 16 patients with histopathologically diagnosed AT/RT and 57 patients with medulloblastoma at our institute. We evaluated their clinical data and MRI findings, including lesion signals, intratumoral morphologies, and peritumoral/distal involvement.
The age of children with AT/RT was younger than that of children with medulloblastoma (2.8 ± 4.9 [0-17] vs. 6.5 ± 4.0 [0-18], p < 0.001), and the overall survival rate was lower (21.4% vs. 66.0%, p = 0.005). Regarding lesion signals on MRI, AT/RT had a lower ADC (cutoff value ≤544.7 × 10 mm /s, p < 0.001), a lower ADC ratio (cutoff value ≤0.705, p < 0.001), and a higher DWI ratio (cutoff value ≥1.595, p < 0.001) than medulloblastoma. Regarding intratumoral morphology, the "tumor central vein sign" was mostly exclusive to medulloblastoma (24/57, 42.1%; AT/RT 1/16, 6.3%; p = 0.007). Regarding peritumoral invasion on T2WI, AT/RT was more prone to invasion of the brainstem (p < 0.001) and middle cerebellar peduncle (p < 0.001) than medulloblastoma.
MRI findings of a lower ADC value, more peritumoral invasion, and absence of the "tumor central vein sign" may be helpful to differentiate AT/RT from medulloblastoma. These distinct MRI findings together with the younger age of AT/RT patients may explain the worse outcomes in AT/RT patients.
胚胎性横纹肌样瘤(AT/RT)比髓母细胞瘤发病年龄更早,预后更差;但在神经影像学上这两种肿瘤实体大多难以区分。我们的研究旨在通过分析其临床和 MRI 特征,来区分 AT/RT 和髓母细胞瘤,以增强治疗计划和预测结果。
2005 年至 2021 年,我们回顾性地纳入了在我院经组织病理学诊断为 AT/RT 的 16 例患儿和髓母细胞瘤的 57 例患儿。我们评估了他们的临床数据和 MRI 发现,包括病变信号、肿瘤内形态以及肿瘤周围/远处侵犯。
AT/RT 患儿的年龄小于髓母细胞瘤患儿(2.8±4.9[0-17]岁比 6.5±4.0[0-18]岁,p<0.001),总生存率也更低(21.4%比 66.0%,p=0.005)。在 MRI 上,AT/RT 的 ADC 值较低(截断值≤544.7×10 mm /s,p<0.001)、ADC 比值较低(截断值≤0.705,p<0.001)和 DWI 比值较高(截断值≥1.595,p<0.001)。在肿瘤内形态方面,“肿瘤中央静脉征”主要是髓母细胞瘤的特征(24/57,42.1%;AT/RT 1/16,6.3%;p=0.007)。在 T2WI 上,AT/RT 更倾向于侵犯脑干(p<0.001)和小脑中脚(p<0.001)。
较低的 ADC 值、更广泛的肿瘤周围侵犯和不存在“肿瘤中央静脉征”的 MRI 表现有助于将 AT/RT 与髓母细胞瘤区分开来。这些不同的 MRI 表现,加上 AT/RT 患儿更年轻,可能解释了 AT/RT 患儿结局更差的原因。